Chou, H.C., N.P. Lang, and F.F. Kadlubar (1995). “Metabolic Activation of N-hydroxy Arylamines and N-hydroxy Heterocyclic Amines by Human Sulfotransferase(s). ” Cancer Res55: 525—9.
2.
Minchin, M.E., J.S. Felton, M.G. Knize, W.M. Burgess, S. Roberts-Thomson, S.M. Pond, I. Stupans, and M.E. Veronese (1989). “Activation of the Food-Derived Mutagen 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine by Rabbit and Human Liver Microsomes and Purified Forms of Cytochrome P-450.” Carcinogenesis10: 357—63.
3.
Minchin, R.F., P.T. Reeves, C.H. Teitel, M.E. McManus, B. Mojarrabi, K.F. Ilett, and F.F. Kadlubar (1992). “N-and O-acetylation of Aromatic and Heterocyclic Amine Carcinogens by Human Monomorphic and Polymorphic Acetyltransferases Expressed in COS-1 Cells.” Biochem Biophys Res Commun185: 839—44.
4.
Ozawa, S. (1997). “Genetic Polymorphisms in Xenobiotic Metabolizing Enzymes as a Determinant of Susceptibility to Environmental Mutagens and Carcinogens in Humans.” Yakugaku Zasshi—J Pharmaceut Soc Japan117: 895—909.
5.
Raftogianis, R.B., T.C. Wood, D.M.Otterness, J.A.Van Loon, and R.M. Weinshilboum (1997). “Phenol Sulfotransferase Pharmacogenetics in Humans: Association of Common SULT1A1 Alleles with TS PST Phenotype.” Biochem Biophys Res Commun239: 298—304.
